Table 1.
Clinical characteristics of 47 patients who received LFP for the first time
| Characteristic | Value |
|---|---|
| Age, years | 65 (37−89) |
| Males | 41 (87) |
| Etiology | |
| HBs Ag positive/negative | 10/37 |
| Anti-HCV positive/negative | 26/21 |
| Child-Pugh class A/B/C | 27/20/0 |
| Hb, g/dL | 12.2 (8.6−17) |
| PLT, n × 104/µL | 12.8 (4−46.4) |
| AFP, ng/mL | 1,538 (2−554,030) |
| AFP-L3, % | 24.5 (0.5−90.9) |
| DCP, mAU/mL | 2,469 (22−295,980) |
| Maximum tumor size, mm | 45 (10−136) |
| Number of tumors (one/multiple) | 3/44 |
| PVTT (main trunk or first branch) | 25 (53) |
Data are expressed as medians (range) or numbers (%) unless otherwise noted. HBsAg, hepatitis B surface antigen; anti-HCV, antibody against the hepatitis C virus; Hb, hemoglobin; PLT, platelet; PVTT, portal vein tumor thrombosis.